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Introduction
As emphasised by the World Health Organization, cancer is a
leading cause of morbidity and death.1 In Europe, it is esti-
mated that there are 3.7 million new cases and 1.9 million
deaths eachyear. Theseﬁgures are expected to increase.2,3 The
most common forms of cancer are female breast cancer,
colorectal, prostate and lung cancer. Together they account
for 50% of all diagnosed cases.4 The economic burden of caring
for patients with cancer reached 126 billion euros in 2009.5
The use of complementary and alternative medicine
(CAM) is high and increasing.6 Results of the latest published
systematic review suggest an increase in point prevalence of
CAM use in patients with cancer from 25% (95% conﬁdence
interval [CI]: 12% to 38%) before 1990 to 44% (95% CI: 38% to
60%) after 2000.7 The point prevalence was lower in Europe
(34%, 95% CI: 25% to 44%) than in North America (46%, 95% CI:
35% to 56%), and it was lower in Scandinavia compared to
German-speaking countries. General use of CAM in the
Danish population was 26% in 2010.8 Four in 10 Danish
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interviews ﬁve themes emerged: concerns and hopes, obstacles and support, internal
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Conclusion The cancer patients in this study sought homeopathy to address their
hopes and concerns and to help them face obstacles and ﬁnd support. They were
actively taking responsibility for their own health and valued the whole person
approach used by their homeopaths. Participants reported improved well-being
both at the physical and mental levels. The results provide a basis for further research
to learn more from patients’ experiences with this intervention. Such knowledge could
potentially be helpful to improve healthcare practitioners’ communication with
patients, and thereby patients’ overall care.
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womenwith breast cancer diagnosis reported CAM use 12 to
16 weeks post-surgery;9 and 49% of patients who had
recently completed conventional colorectal cancer treat-
ment reported some form of CAM treatment in the past
month.10 Although updated prevalence data for CAM use for
all categories of patients with cancer in Denmark are lacking,
these two surveys suggest CAM use among Danish patients
with cancer may be comparable to patients in other coun-
tries. CAM is used by both men and women, and in different
sub-groups of patients.11–16
Homeopathy is a CAM therapy that was developed by
Hahnemann (1751–1843), a German physician who based
his system of medicine on the law of similars—’let like be
cured by like’. It involves consultations with a homeopath
and the prescription of highly diluted homeopathic medi-
cines which can be prescribed in a variety of ways.17
A recently published systematic worldwide review suggests
about 4% (range: 0.7–9.8%) use homeopathy,18 and it is more
commonly used in Europe than in North America.6 It is used
by patients with a variety of clinical problems, including
recurrent respiratory tract infections, migraine headaches,
back pain, fatigue, allergic and skin conditions, sleep dis-
turbances, and mental health problems.19,20
Homeopathy is the second or thirdmost used CAM therapy
by patientswith cancer in Europe.21,22AGerman cohort study
found that patients with cancer using homeopathy are more
likely to beyounger, havehigher education andhigher income,
compared to patients solely using conventional treatment.23
Althoughnoepidemiological studies reportonuseofhomeop-
athy among patients with cancer in Denmark, similar char-
acteristics have been found in Danish breast and colorectal
cancer CAM users.9,10 Results of the German study suggested
that the homeopathy group had a longer disease history than
patients with cancer receiving conventional treatment, indi-
cating that the two groups entered the study at different
disease phases. Their quality of life, levels of anxiety, depres-
sion and fatigue scores were, however, comparable.23 Danish
patients with breast cancer using CAM were found to be less
likely to suffer fromco-morbiddiseases, compared to thosenot
using CAM therapies.9
Whilst it is known that homeopathy is used by a signiﬁ-
cant proportion of patients with cancer,23–28 a search of
databases including AMED, CINAHL, Cochrane Library, Pro-
Quest and SCOPUS, failed to identify any qualitative studies
exploring experiences among patients with cancer with
treatment provided by homeopaths, and it is one of the
areas highlighted for future research.24,29,30Hence, there is a
gap in knowledge of cancer patients’ experiences with
homeopathic treatment. Moreover, no studies have reported
on the use of homeopathy among these patients in Denmark.
Therefore, this study aimed to gain a ﬁrst insight into reasons
for and experience with treatment provided by homeopaths
among Danish patients with cancer.
Methods
The study included a purposive sample of Danish patients
with cancer who had used homeopathy alongside conven-
tional cancer treatment. Semi-structured interviews were
carried out and analysed using thematic analysis.31 We did
not aim for saturation of data, but to provide an initial insight
into experienceswith homeopathic treatment among cancer
patients in Denmark. The study was carried out as part of a
Master of Science (MSc) course at the University of Central
Lancashire (United Kingdom). Ethics approval was obtained
from the University’s Ethics Committee.
Inclusion Criteria
Inclusion criteria for patients: Medical diagnosis of cancer,
current conventional cancer treatment with homeopathy as
an adjunct therapy, having had a minimum of four consulta-
tions with a homeopath and currently being under the care
of a homeopath. Participants had to be at least 18 years of age
and able to speak and read Danish.
We did not limit inclusion criteria to patients with any
particular type of cancer diagnosis to obtain knowledge from
a greater variety of patients with cancer. Including patients
who used homeopathy in parallel to conventional treatment
provided us with an opportunity to compare and contrast
patients’ experiences with the different treatments.
Inclusion criteria for practitioners: Working as a ‘classical’
homeopath, to have a minimum of 5 years of clinical experi-
ence with patients diagnosed with cancer and/or had to be
working at a hospital under peer supervision and seeing at
least 10 patients with cancer per week.
Recruitment
The goal was to interview 12 patients. As part of our recruit-
ment strategy, we askedhomeopaths and aDanish association
for patientswith cancer who are interested in orwhouse CAM
therapies (Kræftforeningen Tidslerne) to inform about the
study. Letters were sent by e-mail to homeopaths identiﬁed
through the Danish Society of Homeopaths, the only profes-
sional organisation for homeopaths inDenmark (whichhas 40
members), asking them to pass on information sheets to their
cancer patients. After several requests to the homeopaths,
three cancer patients contacted the researcher. In addition,we
encouragedpatientswhoparticipated to informother patients
who might fulﬁl the inclusion criteria to participate. Three
patients were recruited through the association and three
through other patients. One patient died prior to study start:
hence, ﬁve were interviewed.
Intervention
Interviewees consulted homeopaths offering individualised
treatment and practising ‘classical homeopathy’. The fact that
treatment was individualisedmeans that it was tailored to the
individual patient. The term ‘classical homeopathy’ is used to
describe the prescription of single homeopathic remedies on
the basis of the individual patient’s symptom picture. This
means that different homeopathic remedies could be pre-
scribed for different patients suffering from the same diag-
nosis, following a homeopathic interview.17 The treatment
was provided by three homeopaths, two Danish and one
German. The two Danish homeopaths were recruited through
the Danish Society of Homeopaths and both had 5 years’
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experience in treating patients with cancer. The German
homeopath was recruited through patients. This homeopath
was seeing at least 10 cancer patients per week in Germany,
but was also treating some patients in Denmark. One practi-
tionerwas amedical doctor, the second a psychologist and the
third was a homeopath as the primary profession.
Data Collection
Potential participants were sent information about the
researchwith the interviewquestions (required by the Ethics
Committee). Questions were kept open to obtain patients’
own experiences and views, and to avoid leading them in a
particular direction. The interview-guide questions included
patients’ reasons for choosing homeopathic treatment, what
they wanted treatment for, their experience of using
homeopathy and conventional treatment in combination,
their overall experience, and any recommendations they
would make for others who might consider consulting a
homeopath. Before this study took place and as a part of the
MSc Homeopathy course at the University of Central Lanca-
shire, United Kingdom, the researcher carried out a literature
search in the area of homeopathic cancer treatment. The
literature search gave the researcher a broad knowledge in
the area. Together with the insight gained from contact with
several people with cancer known to the Kræftforeningen
Tidslerne, the interview questions were developed.
Interviews were conducted by one researcher (CY), who
has a background as a homeopath and qualitative researcher.
The interviewer had not treated any of the included patients,
but her background as a homeopath could potentially inﬂu-
ence interviews. However, through her education and clin-
ical practice, she had extensive training and clinical
experience. This includes training at the polyclinic at the
University of Westminster as part of a Bachelor of Science
Degree in Homeopathy, as well as training in interviewing as
part of a qualitative research project. Her background
enabled her to ask open-ended and non-leading questions,
and to establish a good researcher–participant relation-
ship. We believe this contributed to encouraging patients
to speak freely and share their thoughts and experiences.
Moreover, she used the interview guide as a basis for all
interviews.
The interviewees were asked where they wanted to be
interviewed; either in their home, in an ofﬁce or over Skype.
Four interviewees chose a live interview in their home and
one choose a Skype interview. Semi-structured interviews of
up to 1 hour were scheduled, and interviewees were encour-
aged to stop interviews at any time or to have a break if
needed. Open-ended questions were used, together with
active listening and letting interviewees speak as freely as
possible during interviews. The intentionwas to ensure good
rapport and a rich understanding of interviewees’ thoughts
and experiences, with as little inﬂuence of the researcher’s
pre-determined understanding as possible.
All interviews were audio-recorded and transcribed by
theﬁrst researcher (CY). Transcripts were compared to audio
recordings by another personwho is a professional translator
and who also checked the accuracy of translations from
Danish to English. Moreover, all transcripts were sent back
to interviewees for correction or conﬁrmation. Also, short
overviews of the interviews were sent back to the intervie-
wees for conﬁrmation of the meaning. Four out of ﬁve
participants responded to the transcripts, whereas the ﬁfth
was unable to do so for health reasons. Three out of the four
participants who responded agreed to the transcripts and
summaries as they stood, whereas the fourth had one minor
correction to the transcript, but this did not affect data
analysis.
Data Analysis
Thematic analysis was used to analyse participants’
responses. The researchers have a background as homeo-
paths, which may have inﬂuenced analyses.32 An advantage
of having such a background was that the researchers have
experience in treating patients with cancer and could there-
fore better understand the interviewees’ situation. To limit
the inﬂuence of any pre-determined perceptions of the
intervention, the researchers carefully considered and based
their analyses on interviewees’ responses. Particular caution
was paid to development of any themes that would be in line
with the core principles of homeopathy, which include the
so-called principle of similars and development of patients’
state of health according to a hierarchical model often
referred to as ‘Hering’s observations’.
The interviews were analysed through a process of asses-
sing and revisiting the data transcripts on numerous (more
than 50) occasions and the results are presented in this
article. Interview transcripts were coded,mainly using codes
with patients’ownwords. Codeswere checked and revised as
necessary each time the datawere revisited. Codeswere then
grouped together in accordance with what the researchers
considered to be themes. Each theme was described and
patients’ quotes were used to illustrate each theme. Trust-
worthiness was based on the extent to which themes shed
light on the research question.31,33
Ethics
All proceduresperformed in thestudywere inaccordancewith
the ethical standards of the institutional research committee
and with the 1964 Helsinki declaration and its later amend-
ments or comparable ethical standards. Informed andwritten
consentwasobtained fromall individual participants included
in the study. For conﬁdentiality reasons, participants were
informed that their real names would not be used in the
published results. The name attached to each presented
patient quote is therefore ﬁctitious.
Results
Participants
The goal was to interview 12 persons, but only 6 patients
agreed toparticipate in the interviewstudy, andonediedprior
to start. Thiswas the total numberof patients approachedwho
agreed to participate in the study. The reason for the low
response is not known, but we assume it is partly because
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classical homeopathy is rather unknown in Denmark, so the
number of cancer patients who seek a homeopath is small.
Although we had hoped for a greater age variety in
participants, those included were middle aged or older
(range: 53–85 years). They had experiences with ﬁve differ-
ent types of cancer, which had been ﬁrst diagnosed between
3 and 13 years prior to the study. Some had past experiences
with homeopathy, whereas others did not. Further details
may be found in ►Table 1.
Interviews and Developed Themes
Interviews lasted from 22 to 84 minutes (median 42 min-
utes). The relative brevity of interviews was to reduce the
amount of any distress for participants, most of whom
struggledwith low levels of energy. Five themes representing
the patients’ experiences were developed:
1. Concerns and hopes
2. Obstacles and support
3. Internal health locus of control
4. Whole person approach
5. Improved well-being.
Concerns and Hopes
A common theme was that participants sought out treat-
ment by a homeopath as there was an absence of hope
provided by their conventional practitioners, or they had
lost hope in conventional treatment because of a relapse and
placed their hope with homeopathy.
‘I became aware of homeopathy when I had a relapse of
breast cancer in January 2008. For a rather long time, I had had
some cough andmy general practitioner sentme to the hospital
and they carried out some scans, which showed that I had
water in the lungs and they said that possibly I had metastases
and it was incurable. They couldn’t say what my future
prospects were, but since it was an aggressive type of cancer
they didn’t think I had much time left’. (Sally)
As illustrated by this example, some concerns were
directly associated with the disease and the prognosis.
Others were concerned about side effects of conventional
cancer treatment, which could result in long-term adverse
effects. Claire had learned this through her own family: ‘I
chose to do without the radiation treatment because I think it
has an adverse effect on the body. My sister had both breasts
removed […] and she had radiation treatment and she still has
strong symptoms from it today’.
Interviewees suggested that other patients with cancer
should consider giving it a chance, as illustrated by Sally who
said: ‘I will deﬁnitely recommend trying it and examining
what’s on the market and making an introductory conversa-
tion and seeing if it could work and then try’. Interviewees’
recommendations to consult with a homeopath were based
on their own experiences, what they had learned from other
patients and as a result of what they had been told by their
homeopath, as illustrated by Simon who said: ‘Began at the
homeopath, who had told my wife that he had seen some good
results with cancer and I started […] in 1998/1999’.
Patients also had some concerns about homeopathic
treatment. Karen expressed some doubts associated with
practitioners’ competence: ‘It occurs to me that if you search
for a homeopath, how do you know it’s not a quack?’ Another
participant expressed concerns with using both treatments
simultaneously, as the meaning of new symptoms could be
difﬁcult to interpret. ‘And then I could feel that both the lump
and the scar tissue had become a bit bigger, but it’s difﬁcult to
know if it’s the cancer lump which has grown or if it’s just the
gland that swelled up because some kind of cleansing takes
place. You never know’. (Claire)
So, there was some uncertainty about the treatments and
an acknowledgement of the importance of conventional
cancer treatment, when at the same time being aware of
its limitations and potential risks of adverse effects. None of
the participants suggested replacing conventional treatment
with homeopathy, but to use it as a supplement. Never-
theless, all interviewees saw hope and opportunities in
homeopathic treatment, as illustrated by the following state-
ments: ‘Actually I want to advise everybody else to supplement
immediately no matter if you choose to be operated on or the
radiation treatment or the chemo treatment’. (Claire) And:
‘Find a homeopath, that is my best advice’. (Karen)
Obstacles and Support
Support was a major issue for the interviewees and they
explained how friends and family had helped them to ﬁnd a
homeopath and supported their choice of treatment, as
illustrated by Sally: ‘Then my friends and I started to examine
other alternative possibilities [from conventional treatment]’.
However, interviewees expressed that at times they felt
their autonomy was threatened by healthcare practitioners
as well as their own families. It was difﬁcult for them to be
resolute in their own choice of healthcare. They felt that
Table 1 Participants’ characteristics
Namea Age
(years)
Type(s) of
cancer
Time since
diagnosis (years)
Used homeopathy
prior to diagnosis
Length of interview
(minutes)
Sally 55 Lung, previously breast 3.5 No 56
Karen 53 Ovary and breast 3.0 Yes 84
Simon 85 Prostate, skin 13.0 No 23
Ida 63 Breast 10.0 No 36
Claire 68 Breast 3.5 Yes 42
aFor conﬁdentiality reasons, participants’ real names are not used.
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some healthcare practitioners and family members ascribed
them a passive role, leaving no space for them to be active
and take responsibility for their own health. This felt like an
obstacle to feeling well and it compromised their hope for
healing. One participant expressed this by stating: ‘[…]
because homeopathy isn’t very well known in Denmark,
your friends and family try to talk you out of it too’. (Karen)
Karen alsomentioned howoncologistsmadeher frighten-
ed and angry when they attempted to talk her out of using
other complementary therapies: ‘Once I saw an oncologist
when I got Iscador [a type of CAM therapy that is part of
anthroposophic medicine]. I said I wanted to take it during
chemo treatment and she said she knew what it was; every-
body who had taken it were all dead. And that is just such a
horrible thing to say, right?’
The interviewees felt supported by their homeopaths as it
helped them to talk with someone who they felt was
empathic, someone who understood them and who took
them seriously. Some participants considered the homeo-
path to be ‘[…] a nice person and nice to talk with’ (Simon),
whereas for others the homeopath played amuch bigger role
and was a signiﬁcant source of support. One participant
expressed this as: ‘So yes, but then it’s just that you become
dependent on the homeopath almost, not [fully] dependent on,
but yes, it’s a lifeline you get, it really is. Yes, if I’d only known it
earlier, because [the homeopath] was there for me at once. He
writes warm greetings and I thought all right, I’ve really got
one here who supports me. I could feel that there was one who
would take care ofme and helpmebecome ﬁt again. It has been
good with homeopathy from the beginning’. (Karen)
Internal Health Locus of Control
The interviewees described what can be understood as
health locus of control, a concept which is based on Rotter’s
theory of locus of control.34 Patients with a strong internal
health locus of control (IHLOC) believe their own behaviour
to have a strong inﬂuence on their health, in contrast to
persons with an external health locus of control, where
health is related to external factors that are difﬁcult to
inﬂuence.35
Patients did, to a considerable extent, take responsibility
for their own health and they had a desire to make their own
decisions about any existing treatment options. ‘You [the
oncologist] shouldn’t worry about me at all: I take the respon-
sibility, you don’t have to. […] so, for me, it has been the start of
a long course with all sorts of problems, but also the start of me
taking the matter into my own hands each time there was
something, right’. (Ida)
They felt they had the right to make informed decisions
about their own treatment, and they disliked when they
were told to go home and just do as theywere told. ‘And it was
also like some of the doctors gaveme the impression to go home
to your kitchen. We take care of this, it’s our business: [...] they
meant it in a nice way, but there are many of us who just can’t
think this way. And I have to know what’s going on so I asked:
What’s it called the chemo treatment, what does it consist of or
e.g. how is a biopsy carried out? [...] I asked and I asked and
then I went home and searched with my computer and then I
had even more questions and I posed every single question
every time and they were so tired of me. And I don’t feel this is
fair’. (Karen)
Other patients described oncology practitioners who
supported their freedom of choice in healthcare, thereby
supporting patients’ IHLOC. ‘I think that gradually in the
hospital service you meet with the opportunity to choose
what you can use. Of course they tell you what solution they
ﬁnd as the best, and that’s fair enough, but there are some
doctors who are sensible and say that it’s okay you take what
you can use and it’s your choice. […] And one of them said that
if you feel like it stresses you, if we suggest chemo therapy, then
we should stop suggesting it. And I said that I should under no
circumstances have the chemo and then she wrote in my
papers: No chemo’. (Claire)
Patients’ strong IHLOC was associated with not automa-
tically accepting what they heard. The interviewees ques-
tioned what they were told both by the conventional
healthcare practitioners and by the homeopaths. Sally did
not agree with her homeopath and chose another solution
than suggested. ‘I was […] asked if I would consider […] taking
a break from the chemo. They thought my ﬁnal course would be
better, because their experience was that especially breast
cancer women got painful ﬁnal courses, and they thought that
this would bemuch better with the homoeopathy, so they could
help me have a better death. Then I went home and thought
about it […] but it was too early. I was simply not ready […]
and I chose to continue the chemotherapy […]’
Participants searched for information, for example, over
the Internet and tried to understand how certain treatment
modalities worked and what results they could expect. They
wanted tomake informed choices. They did not choose to use
either CAM or conventional treatment, but they combined
different treatment modalities in a way that seemed ‘logical’
or ‘right’ to them. They showed compliance both to conven-
tional treatment offers and check-ups, as well as dietary
advice offered by the homeopaths when they felt this made
sense. However, after weighing the pros and cons, they could
decide to abstain from a diagnostic or therapeutic approach
if they believed it was associated with considerable disad-
vantages. Such decisions were not easy to reach, but patients
still made what they felt was their choice. Claire expressed
this as: ‘When I chose to do without that chemo treatment I
knew I had to try something else […]. Now I have this check-up
on Friday and I have chosen to do without the mammography
because the lump I have is placed almost right under the armpit
and then I don’t see any reason that the breast should be
manhandled. When I had the last mammography [the nurse]
said they had to stop it because the pictures couldn’t get better
where the lump was and then I thought ok then it’s not useful
[…] I really want to have these check-ups because it’s nice after
all to follow the development. It’s really difﬁcult to judge if it’s
swollen glands or if it’s scar tissue or if it’s cancer […]’.
Whole Person Approach
Participants’ statements were related to a holistic way of
thinking. As Karen expressed it: ‘You come as a whole human
being. You can’t just come as a body’. The interviewees felt
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these views and values were shared by their homeopaths,
and they felt appreciated as a whole person.
Sally said: ‘Obviously the advantage of the homeopathic
approach is that you are interested in the whole person, which
is what you really miss in the conventional system. If you have
metastases in the lungs then it’s only the 30 cm under the head
and down to the navel that is interesting [...] It’s really like
you’re divided in small sections and you can’t discuss the other
things […]. Not to mention the mental part—the fact that the
mental and physical things hang together, that is very impor-
tant too’. In addition, Sally felt that homeopathy had helped
her with physical symptoms: ‘Ten years ago, as I went to the
chemo treatment for the ﬁrst time, I was very, very ill. Each
time I’d had a treatment, I was ill in bed from 3 days to 1 week
and I threw up and felt really, really bad and had headache, and
this time I haven’t felt these symptoms, so I believe homeopathy
has helped with this’.
In this quote, Sally explains what a reductionist way of
thinkingwithin thehealthcare systemmeans to her. She feels
divided into small parts and not seen as a human being. She
wants to be looked at as a whole person where both her
mental and physical problems are seen as connected and
taken care of. Conventional cancer care clinicians were
described as focussing on the local cancer symptoms, rather
than on the whole person.
Improved Well-Being
Participants reported howhomeopathy had helped themcope
with symptoms of depression, poor memory and concentra-
tion, aswell asphysical symptomssuchasa tenniselbow, acute
winter illnesses and backache. They found that homeopathy
improved their overall well-being both physically and men-
tally, and the low energy often seen in patients with cancer.
Claire noted how she felt ‘[…] really well with the homeopathic
therapyandmentally I can feel a change too. It simply givesmore
energy’. Sally recalled that ‘Iwas afraid of relapsing intoa severe
depression once again, which I’ve had before and been hospita-
lised with, but I believe the homeopathic therapy helpedme step
down the [conventional medication]. After a few months I was
done with it and I’m really happy about that. I haven’t seen a
trace of depression since then’.
Another patient described a multitude of side effects
arising from conventional treatment. After homeopathic
treatment, she described ‘becoming human again’: ‘[My]
homeopath, then she said, yes but then there’s these side effects
from the radiation treatment: we’ll handle them in this and
that way and there was the side effects from the chemo, we’ll
handle them in this and that way [...]. And that helped for the
side effects and that is amazing, right? [I] couldn’t feel my body
or skin, I couldn’t see, watch television, read books or think. I
couldn’t drive a car, I couldn’t feel my feet. I was on the brink at
this time. My nails had started to turn blue and I was so ill. And
then the common things: You can’t taste or smell anything, and
I couldn’t feel my hands. I burned myself and cut myself, you
see. I could barely eat by myself because sensation was gone
because of the chemo treatment. That is what the uncomfor-
table thing is: I thought I would never become a human again.
But thanks to homeopathy [I did so]’. (Karen)
Summary of Themes
This qualitative semi-structured interview study suggests
that patients with cancer sought treatment by a homeopath
in response to concerns about conventional medical treat-
ment, relapses and the poor prognoses offered. Their choice
of homeopathy as a supplement to conventional cancer care
was associated with increased hopes of better health. Parti-
cipants felt supported by their homeopaths and this was
sometimes in contrast to a perceived lack of support from
oncologists, families and friends.
Participants felt their right to self-determination had been
compromised and they appreciated the approach taken by
their homeopaths. In particular, the holistic worldview held
by their homeopath was welcomed, with participants
describing how enhanced mental and physical well-being
was the main outcome of the treatment. However, this did
not mean that the interviewees had uncritically accepted the
treatment that was offered by homeopaths. Their descrip-
tions leading to the theme of the IHLOC suggest they sought
information from various sources to make informed deci-
sions for their own healthcare. The complementary homeop-
athy treatment was described as a whole-person approach
contributing to improvements in patients’ feeling of well-
being.
Discussion
Five themes were developed in this ﬁrst qualitative study
providing an initial insight into reasons for the use of and
experience with homeopathic treatment among patients
with cancer. Although no former qualitative study has
reported on the experienceswith homeopathy in this patient
group, some have reported on experience with other CAM
therapies.36–38
As in the current homeopathy study, reasons that patients
choose CAM treatments may include CAM practitioners’
focus on improving well-being.36,37 There is some evidence
to suggest that patients with cancer, and using homeopathy
as an adjunct to usual cancer care, experience improvedwell-
being and better quality of life,25,28 as was mentioned by all
ﬁve interviewees in the current study. Following homeop-
athy treatment, others also found improvement in the well-
known fatigue symptom of patients with cancer.25
The use of other CAM therapies by patientswith cancer has
been found to be partly motivated by their concerns, in
particular concerns about side effects associatedwith conven-
tional treatment.38–40Asa result, theremaybea risk that some
patients choose to decline an offer of conventional treatment.
The interviewees in this study used homeopathy as a comple-
ment (and not an alternative) to conventional cancer care,
which is advisable and ethically appropriate to ensure patient
safety. Somedecidednot touse all the interventions theywere
offered. These decisions followed if patients anticipated that
the risks of side effects outweighed any potential beneﬁts.
Such decisions were not taken lightly, but only after careful
consideration of the information provided by healthcare prac-
titioners, and on the basis of patients’ own experiences and
anecdotal reports from other patients. Patients with cancer
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whowere using CAM in some studies had a strong need to be
involved in and control decisions that would affect their
healthcare.39 Deciding not to take up an offer of some form
of cancer treatment may be associated with concerns about
side effects fromconventional cancer treatment.40The need to
stay in control of healthcare decisions was in our study
described through the theme of a strong IHLOC. Strong IHLOC
has been associatedwith high CAM use and high CAM apprai-
sal.41Wesuspect that high IHLOCbecamea theme inour study
as these patients are more likely to seek other treatment
options, as opposed to patientswith low IHLOCwhowewould
expect to be more likely to rely solely on the advice given by
oncologists and therefore use conventional treatment only.
Are patients with a high IHLOC also more likely to seek
homeopathy treatment because they feel no hope for cure is
offered by their healthcare practitioners, and they refuse to
accept a poor prognosis? The interviewees in this study
described consulting with homeopaths, as little or no hope
was given by their conventional practitioners, or they had
lost hope in conventional treatment because of a relapse.
Some patients experienced difﬁculties in the communica-
tion with oncologists about CAM treatment. Karen mentions
how ‘they tried to talk her out of it’. Rossi proposes the idea
that reluctance of giving false hope of cure among patients
with cancer may impact oncologists’ (lack of) integration of
CAM in oncology departments.42 We suggest oncology prac-
titioners should take patients’ concerns andwishes seriously
and facilitate constructive patient–clinician communication.
A form of communication where patients’ views and wishes
are rejected could be a potential risk factor from an oncology
practitioner’s viewpoint, as it may lead to patients choosing
to reject or discontinue conventional cancer care.43 A more
open and positive form of communication, where clinicians
listen to patients’ concerns and wishes, is more likely to
result in patients using CAM therapies as a complement,
rather than an alternative. Such communication is likely to
facilitate a better therapeutic relationship, it provides a
better basis for shared decision-making in healthcare, and
it is more in line with a patient- or person-centred approach
to the relationship and the treatment.
Strengths and Weaknesses of This Study
This qualitative studywas theﬁrst to examine reasons for use
of and experience with homeopathic treatment among
patients with cancer. It was also theﬁrst ever study assessing
experiences with homeopathy among Danish patients with
cancer. The small number of interviewees was diagnosed
with a diverse range of cancer types (lung, female breast,
prostate, skin and ovarian cancer). The strengths of the
qualitative approach are the exploration of subjective view-
points and the in-depth information among patients with
cancer.
The small sample size is aweakness of this study. This was
in part due to the fact that the study took place in Denmark,
where ‘individualised’ or ‘classical’ homeopathy is relatively
unknown. This may have inﬂuenced the experiences of the
interviewees when discussing homeopathic treatment with
their oncologists and it may also have had an impact on
which patients sought homeopathic treatment. It is possible
that their experience of using homeopathic treatment as an
adjunct to usual cancer care may vary among different
groups of cancer patients (tumour location and stage of
cancer), and experiences may be different for patients in
other countries. We did not seek to address issues surround-
ing the generalisability or transferability of the study, which
could be aimed for in a future meta-synthesis including
qualitative studies which also use approaches such as sys-
tematic sampling and triangulation.44
Only a single male patient participated, thereby providing
little insight into ‘the male perspective’ in this particular ﬁeld
(►Table 1). Patients’ age ranged from 55 to 85 years. The
results might have been different had younger patients been
interviewed. To reduce any strain put on patients, interviews
were kept as short as possible, which may also have contrib-
uted to somewhat limited description of the developed
themes.
A number of approaches were used to contribute to the
trustworthiness of the research. This included the use of a
‘bottom up’ approach, basing the development of codes and
themes on the data, rather than a ‘top down’ approach which
would start out with a pre-deﬁned framework of understand-
ing. Some of the questions were pre-determined in order to
learn from experiences with, and views of, the intervention
among patients with cancer. Questions were, however, open-
ended (as opposed to closed ‘yes/no’ questions) to capture
better the patients’ own understandings. The developed
themes provide an initial and limited insight into experiences
with homeopathic treatment among patients with cancer.
Recommendations
Future research should be conducted to consider the themes
identiﬁed through this small qualitative study, to expand on
the description of themes, as well as to examine additional
issues considered to be of importance to cancer patients
consulting with homeopaths. This should include explora-
tion of positive as well as negative experiences that patients
may have with this intervention. Researchers could also
consider limiting inclusion criteria to certain groups of
patients with cancer, as some may have different prognoses
and may choose different treatment pathways. Communica-
tion and collaboration between CAM and conventional prac-
titioners should be explored. Thismay contribute to ensuring
the safety of patients.
Conclusion
Five themes developed through this study provide initial
insight into reasons for, and experiences with, the use of
treatment provided by homeopaths as an adjunct to usual
cancer care. The cancer patients in this study sought homeop-
athy to address their hopes and concerns and to help them face
obstacles and ﬁnd support. They were actively taking respon-
sibility for their own health and valued the whole person
approachusedby theirhomeopaths. Theparticipants reported
improvedwell-being at the physical andmental levels. Further
research is needed to learn more from experiences with this
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intervention among patients with cancer and about the com-
munication between clinicians and patients about such
treatment.
Highlights
• This is theﬁrst qualitative studyexploring cancer patients’
experiences with homeopathy.
• Patients described concerns, hopes, obstacles and support
in their treatment.
• Homeopathy was considered to be a whole person
approach.
• Patients felt in control of their treatment and their well-
being improved.
• This was a small study andmore research is needed in this
clinical ﬁeld.
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